Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

 

 

 

 

 

 

Новости/Аналитика

A visual illustration of a falling CBD market

14.09.2022

The desire of companies specializing in the production and sales of CBD products to at least stay in the "bear" market leads not only to significant discounts in sales, but also to active efforts to conquer "new territories" for the sale of their products.

On the pages of the specialized electronic edition of national cannabis growers, it was already explained “What the situation on the CBD market in the USA and Canada says”. Another confirmation of the rapid decline in the value of the pharmaceutical CBD market is an elementary analysis of the situation around the financial condition of its individual players, revealed during a careful review of just one completed transaction.

Announcement by Canadian pharmaceutical company RAMM Pharma Corp. on the acquisition of CBD manufacturer HemPoland from The Green Organic Dutchman Holdings Ltd. (TGOD) for approximately $920,000 in cash is a telling fact. Canadian TGOD paid about $15.5 million to acquire HemPoland in 2018, including $7.75 million in cash. This indicator is one of the clear signs of a trend of mass devaluation of companies involved in the production of vegetable cannabidiol against the backdrop of increasing competition in this segment of modern cannabis production.

Acquisition of HemPoland follows purchase of RAMM Pharma Corp. Sicilian company "Canapar Corp." in May 2021 through a cashless share swap of approximately $22 million. HemPoland currently sells 11 CBD products out of 12,000 under review by the UK Food Safety Authority (FSA). This is one of the companies that, among a host of other players in the declining CBD market, is trying to participate in the over-the-counter sales of cannabinoid products in the highly liquid UK market.

It is necessary to draw the attention of our esteemed readers and listeners to the fact that RAMM and TGOD, trading their shares on the Canadian Stock Exchange, have been constantly losing financial resources lately and continue to fight for their existence in the midst of the collapse of the CBD market, which is observed throughout the world.

After losing a total of $16 million between 2019 and 2021 on $11 million in revenue, RAMM lost $3.3 million in the first half of 2022 alone on about $1.4 million in revenue. profit in no year since going public in 2019.

TGOD, founded in 2012, went public in 2018. Its biggest annual loss exceeded $149 million in 2019. According to financial reports, the company recorded a loss of $133 million in 2020 and another $29.5 million in 2021. In the first half of this year, TGOD lost $14.5 million on revenue of $17 million.

Commentary of the specialists of the “Ukrainian Industrial Hemp the Association”

Understanding that “RAMM Pharma Corp.” making cannabis-based pharmaceuticals such a significant loss speaks not only of the problems with the marketing of CBD products in both North America and Europe. The desire of companies specializing in the production and sale of CBD products to at least stay in the “bear” market leads not only to significant discounts in sales, but also to active efforts to conquer “new territories” for the sale of their products. Unfortunately, Ukrainian officials, instead of creating conditions for the development of national companies seeking to work in this highly liquid market, through lobbying changes to the current legislation of our country, create favorable conditions for the unhindered entry of foreign pharmaceutical companies into it, while simultaneously creating unbearable conditions for the existence of already stable operating sectors modern hemp growing in Ukraine. Moreover, this is done contrary to the existing trends of the global market to increase the area of industrial hemp for the full use of hemp raw materials in various areas of modern management.

< Previous article   Next article >

Потенциал национального рынка каннабиноидных косметических препаратов
17.01.2024

В Украине потребитель готов для выведения на рынок линейки национальной профессиональной CBD косметической продукции

Объявления
Все объявления »
 
 

facebook

telegram

twitter